Bausch Health Companies Inc. Common Stock (BHC)
R&D Expenses
$173.00M
Quarterly · Period ending: · USD
BHC R&D Expenses
Latest reported$173.00Mperiod ending
Latest reported$173.00Mperiod ending
BHC Quarterly R&D Expenses ($0.00 → $173.00M)
Quarterly R&D Expenses
High-resolution chart · PNG
BHC r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 13,913,000 | |
| 11,407,000 | |
| 4,238,000 | |
| 22,713,000 | |
| 13,942,000 | |
| 11,766,000 | |
| 13,600,000 | |
| 7,700,000 | |
| 6,500,000 | |
| 5,300,000 | |
| 5,300,000 | |
| 4,000,000 | |
| 4,100,000 | |
| 4,000,000 | |
| 0 | |
| 4,900,000 | |
| 2,300,000 | |
| 3,100,000 | |
| 1,600,000 | |
| 1,800,000 | |
| 2,000,000 | |
| 2,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 600,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |